Teva Pharmaceutical Industries (TEVA)
(Real Time Quote from BATS)
$16.39 USD
+0.13 (0.80%)
Updated Jun 28, 2024 10:52 AM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Brokerage Reports
Teva Pharmaceutical Industries Ltd. [TEVA]
Reports for Purchase
Showing records 381 - 400 ( 457 total )
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Reported in-line second quarter results with total sales of $5.0 billion (up 2%) and adjusted
Provider: G.RESEARCH, LLC
Analyst: KEDRA K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
We are dropping coverage due to the departure of the covering research analyst
Provider: NATIONAL ALLIANCE CAPITAL MARKETS
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
INITIATING COVERAGE AT BUY AND TARGET PRICE $64
Provider: NATIONAL ALLIANCE CAPITAL MARKETS